CAC
AGN

Cowen and Company’s Allergan plc AGN Stock Holding History

Cowen and Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,274
Closed -$1.29M – 564
2020
Q1 		$1.29M Buy
+7,274
New +$1.37M 0.3% 71

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Cowen and Company's AGN Position: Q2 2020 in Review

Cowen and Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,274 shares — an estimated $1.29M sold.

Cowen and Company first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $1.29M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cowen and Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cowen and Company sold 7,274 Allergan plc shares in Q2 2020, an estimated $1.29M.
  • Cowen and Company first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Cowen and Company's Allergan plc position peaked at $1.29M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cowen and Company's 13F filing for Q2 2020, filed 13 Aug 2020.